Rapid Novor has published a study that highlights the power of combining de novo antibody protein sequencing with ...

Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable ...

The team turned to human antibodies to minimize these risks and enhance treatment effectiveness. Their study, published in ...

The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...

Innovent Biologics has reported that its trial of picankibart (IBI112) in Chinese patients with ulcerative colitis met the ...

Ability Biologics ("Ability") is proud to announce a new partnership with Mila - Quebec Artificial Intelligence Institute.

A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated ...

The first human case of mpox was recorded in 1970 in the Democratic Republic of the Congo ... In a planned interim analysis, study investigators measured antibody levels two weeks after the second ...

A meta-analysis of 14 studies found that serum levels of anti-BP180 autoantibody strongly correlated with the severity of bullous pemphigoid.

GigaGen awarded US BARDA contract valued upto $135.2 mn to develop recombinant polyclonal antibody therapies for BoNT and an additional biothreat: San Carlos, California Monday, O ...

Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced the upcoming presentations of pemivibart data from ...